Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Background Current clinical practice guidelines (CPGs) for posttraumatic stress disorder
(PTSD) offer contradictory recommendations regarding use of medications or psychotherapy …

Objective: Posttraumatic stress disorder (PTSD) is an important mental health issue in terms
of the number of people affected and the morbidity and functional impairment associated …

BackgroundPharmacological treatment is widely used for post-traumatic stress disorder
(PTSD) despite questions over its efficacy. AimsTo determine the efficacy of all types of …

This revision of the 2005 British Association for Psychopharmacology guidelines for the
evidence-based pharmacological treatment of anxiety disorders provides an update on key …

Context Atypical antipsychotic medications are commonly used for off-label conditions such
as agitation in dementia, anxiety, and obsessive-compulsive disorder. Objective To perform …

In this report, which is an update of a guideline published in 2002 (Bandelow et al. 2002,
World J Biol Psychiatry 3: 171), recommendations for the pharmacological treatment of …

Anxiety disorders, as a group, are among the most common mental health conditions and
frequently cause significant functional impairment. Both psychotherapeutic and …

Background: Pharmacological approaches are widely used for post-traumatic stress
disorder (PTSD) despite uncertainty over efficacy. Objectives: To determine the efficacy of all …

The selective serotonin reuptake inhibitors (SSRIs) are considered the first-line
pharmacological treatment for PTSD. However, even when treated with this class of drugs …